Total Health

Anthony S. Fauci, M.D.

Director, NIAID

Anthony S. Fauci, M.D. is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health, where he oversees an extensive research portfolio focused on infectious and immune-mediated diseases. He serves as one of the key advisors to the White House and Department of Health and Human Services on global HIV/AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats. He is the winner of numerous prestigious awards including the Presidential Medal of Freedom, the National Medal of Science and the Lasker Award for Public Service.

Arianna Huffington

Chief Executive Officer, Thrive Global

Arianna Huffington is the founder and CEO of Thrive Global, the founder of The Huffington Post, and the author of 15 books, including, most recently, Thrive and The Sleep Revolution. In 2016, she launched Thrive Global, a leading behavior change tech company with the mission of changing the way we work and live by ending the collective delusion that burnout is the price we must pay for success.

She has been named to Time Magazine's list of the world’s 100 most influential people and the Forbes Most Powerful Women list. Originally from Greece, she moved to England when she was 16 and graduated from Cambridge University with an M.A. in economics. At 21, she became president of the famed debating society, the Cambridge Union.

She serves on numerous boards, including Onex and The B Team.

Her last two books, Thrive: The Third Metric to Redefining Success and Creating a Life of Well-Being, Wisdom, and Wonder and The Sleep Revolution: Transforming Your Life, One Night At A Time, both became instant international bestsellers.

Anne Wojcicki

CEO and co-founder, 23andMe

Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Presently, 23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries, and the company has created a proven and standardized resource for finding new genetic association and confirming genetic loci discovered by others. Under Anne’s leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology. Getting access to and understanding her own genetic information had always been one of her ambitions.

Michael J. Dowling

President and Chief Executive Officer, Northwell Health

Michael J. Dowling is President and Chief Executive Officer of Northwell Health (formerly the North Shore-LIJ Health System). With 21 hospitals, more than 450 outpatient physician practices and a full complement of long-term care services, Northwell Health is one of the nation’s largest health systems, with nearly $8 billion in annual revenue. Michael served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services. Earlier this month, Mr. Dowling spoke to the audience of the HEP Annual Meeting about issues affecting large hospital systems, the healthcare industry in general, and the Hofstra Northwell School of Medicine.

Michael A. Slubowski

President and Chief Executive Officer, Trinity Health

Mike Slubowski, president and chief executive officer, Trinity Health provides executive leadership to the 22-state, 92-hospital Catholic health system, serves on the Trinity Health Board of Directors, and has full accountability for the overall achievement, advancement, and success of the system.

Immediately prior to this role, Slubowski served as the system's president and chief operating officer, overseeing all system operations, and focusing on ensuring that people, processes, IT systems and resources were in place to achieve successful operations.

Slubowski's more than 40 years as a health care executive include tenures as president and CEO of Sisters of Charity of Leavenworth Health System, in Colorado, as president, Health Networks, for Trinity Health before its 2013 merger with Catholic Health East, and in executive leadership positions at health systems including Henry Ford Health System in Detroit, Michigan; Samaritan Health Services in Phoenix, Arizona; and Providence Hospital in Southfield, Michigan.

Slubowski holds a bachelor's degree in business administration and a master’s degree in business administration from Wayne State University in Detroit, Michigan. He completed advanced health care leadership training through an Advanced Leadership Institute conducted by the University of Michigan School of Business and sponsored by the National Center for Healthcare Leadership. He also holds fellowships in the American College of Healthcare Executives and the American College of Medical Practice Executives.

Paul Stoffels

Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson

Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of people around the world.

Paul spearheads the Johnson & Johnson research and product pipeline by leading teams across all our sectors to set the companywide innovation agenda, discovering and developing transformational healthcare solutions. He also is responsible for the safety of all products of the Johnson & Johnson Family of Companies worldwide, and steers the company’s global public health strategy to make innovative medicines and technologies accessible in the world’s most vulnerable communities and resource-poor settings.

Paul’s commitment to fueling innovation and finding the best science, wherever it exists, is the driving force behind the launch of Johnson & Johnson Innovation in 2013, which he now leads to foster science and technology through strategic partnerships, licensing and acquisitions. Paul also oversees JJDC, the oldest corporate venture fund in the life science industry.

Previously, in his role as Worldwide Chairman, Pharmaceuticals, Paul led the transformation of the pharmaceutical research and development pipeline for Janssen Pharmaceutical Companies of Johnson & Johnson, driving a fundamental shift in the R&D paradigm that is now a model in the industry for productivity and innovation. Under his leadership, Janssen rejuvenated its pipeline, launching multiple new medicines and making a difference for people all over the world.

Prior to this, Paul held various R&D leadership roles within the pharmaceutical sector of Johnson & Johnson. He joined Johnson & Johnson in 2002 with the acquisition of Virco and Tibotec, where he was Chief Executive Officer of Virco and Chairman of Tibotec, and led the development of several breakthrough products for the treatment of HIV that helped to transform this devastating disease from a death sentence to a chronic and treatable condition.

Paul studied Medicine at the University of Diepenbeek and the University of Antwerp in Belgium and Infectious Diseases and Tropical Medicine at the Institute of Tropical Medicine in Antwerp, Belgium. He began his career as a physician in Africa, focusing on HIV and tropical diseases research.

Greg A. Adams

Chairman and Chief Executive Officer, Kaiser Permanente

Greg A. Adams is the chairman and CEO of Kaiser Foundation Health Plan, Inc. and Hospitals.

Adams assumed the role of chairman and CEO in December 2019.

A nationally recognized leader and a champion of health care transformation, improving access, and pushing for better health outcomes, Adams, since his time with Kaiser Permanente, has been driving the comprehensive work focused on growing the organization’s membership, improving affordability for members, and transforming and expanding access to care.

Adams has 30 years of leadership experience as a senior health care executive and has played an integral role in leading the transformation and improvement of patient care outcomes at Kaiser Permanente. In addition, Adams has been a key leader in driving the organization’s mission of providing high-quality, affordable care and coverage; strengthening the culture; and ensuring Kaiser Permanente continues to be a great place to work.

Prior to his current role, Adams served as executive vice president and group president, with direct responsibility for health plan and hospital operations in all 8 Kaiser Permanente regions, serving 12.4 million members and operating 39 hospitals and 715 medical office facilities. Adams' accountabilities included co-leading Enterprise Shared Services to serve the operational needs of the regions and leading Kaiser Permanente’s national Medicare care delivery strategy. Prior to that, he was named regional president of Kaiser Permanente for Northern California in April 2008. In July 2013, he was appointed executive vice president.

Adams is a member of the board of directors for America’s Health Insurance Plans and is both a governor and steward within the Global Health and Healthcare Community at the World Economic Forum. Additionally, Adams is a member of the Business Roundtable, the National Association of Health Services Executives, and The Executive Leadership Council. He also serves on the board of directors for the Los Angeles Philharmonic Association. He is a past member of the California Chamber of Commerce board of directors and the California Hospital Association’s board of trustees.

Adams has a bachelor’s degree from Oglethorpe University in Atlanta and graduate degree from Wichita State University.

George Yancopoulos

Chief Scientific Officer, Regeneron

George D. Yancopoulos, MD, PhD, has built and managed Regeneron alongside Dr. Schleifer since 1989. Dr. Yancopoulos is currently President and Chief Scientific Officer and has served on the board since 2001. Dr. Yancopoulos, along with key members of his team, is the principal inventor of Regeneron’s seven FDA-approved drugs and foundational technologies, including the TRAP technology, VelociGene® and VelocImmune®. He has been named an Ernst & Young Entrepreneur of the Year and has been pivotal in creating the science-driven, collaborative and highly-productive R&D culture at Regeneron. This unique environment has earned the company widespread recognition, including repeatedly being named one of the "most innovative companies in the world" by Forbes magazine. Dr. Yancopoulos was the 11th most highly cited scientist in the world in the 1990s, and in 2004 he was elected to be a member of the National Academy of Sciences. Dr. Yancopoulos attended the Bronx High School of Science and received his MD and PhD from Columbia University.

Dr. Anton Decker

President, International, Mayo Clinic

G. Anton Decker, MBBCh, is president of International at Mayo Clinic, a not-for-profit, academic health system. With a workforce of 70,000, Mayo Clinic earns $14 billion in annual revenue while caring for more than 1.2 million patients each year from all 50 states and more than 140 countries.

Prior to returning to Mayo Clinic in 2019, Dr. Decker was president of Health Innovation for Bon Secours Mercy Health, an $8 billion net revenue international health system with 48 hospitals and 60,000 staff. He also served as chief clinical officer for Mercy Health, president of Mercy Health Physicians, chief medical officer and board chair for Banner Medical Group, and board chair for Banner Health Network.

Dr. Decker, a gastroenterologist, has authored more than 60 peerreviewed papers and has been an invited speaker at numerous institutions and meetings, most with a focus on health care economics. He is the chair of the American Gastroenterological Association Practice Management and Economics Committee.

Born in South Africa, Dr. Decker completed medical school at the University of the Witwatersrand, Johannesburg, and trained at Mayo Clinic College of Medicine and Science as a resident and fellow. He also earned a master’s degree in health administration.

Having worked in four countries, Dr. Decker brings a global perspective to collaboration with people from all backgrounds and experiences.

Noubar Afeyan

Founder and Chief Executive Officer, Flagship Pioneering

More info coming soon.

Michael Neidorff

Chairman, President and Chief Executive Officer, Centene Corporation

Michael Neidorff is Centene Corporation's chairman, president and chief executive officer. A recognized leader in the industry, he is committed to building a multi-national healthcare enterprise while upholding Centene's local approach to healthcare. He demonstrates a history of successfully implementing programs and services under Medicaid, Medicare, and commercial managed care. Under his leadership, Centene has grown from a $40 million corporation to a publicly traded (NYSE: CNC), FORTUNE® 100, diversified, healthcare enterprise.

Michael Neidorff became president and chief executive officer of Centene Corporation in 1996. The company established operations in all 50 states – to become the largest Medicaid managed care organization in the U.S. and the top insurer in the Health Insurance Marketplace. Revenues are expected to exceed $110 billion in 2020. Centene now delivers high-quality and accessible healthcare to nearly 1 in 15 individuals across the nation.

Centene provides accessible, cost-effective coverage to the rising number of under-insured and uninsured people in communities across the U.S. Under Mr. Neidorff's leadership, Centene has expanded from operating Medicaid health plans solely in Wisconsin and Indiana, to operations in every state, serving more than 23 million managed care and TRICARE eligible individuals.

Mr. Neidorff's record of transformative leadership is proven in the healthcare industry. In 1985, he started Physicians Health Plan of Greater St. Louis, a subsidiary of UnitedHealth Group. He served as the president and chief executive officer from 1985-1995, and grew the plan to be one of UnitedHealth Group's most successful and profitable plans in the country. From 1995-1996, he served as the regional vice president of Coventry Health Care, Inc., a publicly traded managed care organization, and as the president and chief executive officer of one of its subsidiaries, Group Health Plan Inc. in St. Louis. He also served in international senior executive positions at Miles Laboratories/Bayer AG.

Michael Neidorff dedicates significant time to civic organizations. He is a board member of the National Urban League and served as its chairman from 2014-2019. In 2015, he was inducted into the Hall of Fame for Junior Achievement of Greater St. Louis. He served as a member of the board of directors for the Greater St. Louis Boy Scouts of America since 1990, serving as Pathfinder district chair, vice chairman and chairman of the Special Needs Committee, vice president of Finance, and council president. Mr. Neidorff is a member of the board of trustees for Trinity University in San Antonio, Texas, his alma mater, and previously served as chairman of the board.

Jason Gorevic

Chief Executive Officer, Teladoc Health

Jason Gorevic is chief executive officer and a member of Teladoc Health's board of directors. Since taking the reins in 2009, he has led Teladoc Health to its position today as the world leader in virtual care, achieving significant growth in revenue, membership, and telehealth utilization. Under his leadership the company has established a proven track record of successfully shaping the market and driving healthcare transformation by executing on the strategic vision, delivering award-winning innovation, and effectively integrating each corporate acquisition.

Nationally recognized as a thought leader and trailblazer in the virtual delivery of healthcare, Mr. Gorevic is fueled by a passion for improving healthcare outcomes and providing universal access to care. His extensive career in healthcare began at Oxford Health, and he has also held executive leadership roles at WellPoint, Inc. (now Anthem, Inc.) and Empire BlueCross BlueShield.

He holds a Bachelor of Arts in International Relations from the University of Pennsylvania.

Dr. Susan Turney

Chief Executive Officer, Marshfield Clinic Health System

Dr. Susan L. Turney is the CEO of Marshfield Clinic Health System (MCHS), taking on that role September 1, 2014. Through its entities, MCHS provides patient care, research, education, health care technology and health insurance for Wisconsin and beyond.

She is recognized as a national thought leader in health care and expert in strategic planning, executive management and external relations. She is sought out as a speaker by national organizations to discuss the business of this industry and is a member of the Modern Healthcare CEO Power Panel, including representatives of the nation’s largest hospital, physician practice, insurer, trade association and think tank organizations.  She was named to Modern Healthcare’s list of 50 Most Influential Physician/Clinical Executives from 2012-2016, 2018, 2019, 2020 and on its list of 100 Most Influential People in Healthcare in 2012- 2014, and 2019. Dr. Turney received the Wisconsin Medical Society’s Directors Award in 2017.  She was named to Becker’s Hospital Review’s list of 27 Female Physician Executives to know in 2018 and named Distinguished Leader by MGMA-ACMPE in 2018. Dr. Turney was named to Becker’s Hospital Review’s list of 105 Physician Leaders to Know in 2019.

Prior to her current MCHS position, Dr. Turney was President and CEO, Medical Group Management Association (MGMA), the leading association for medical group practice administrators and executives, from 2011-14. She was CEO and Executive VP of the Wisconsin Medical Society from 2004-11.  She is a Fellow in the American College of Medical Practice Executives (FACMPE), having earned that distinction in 2005.

For 22 years, from 1982-2004, Dr. Turney was an internal medicine physician at Marshfield Clinic, serving in education and leadership roles and as medical director for Patient Financial Services from 1995 to 2004.

Dr. Turney, a native of Mellen, Wisconsin, graduated from Northland College, Ashland, Wisconsin; and the University of Wisconsin-Madison School of Medicine and Public Health. She completed her internal medicine residency at Marshfield Clinic/Ministry Saint Joseph’s Hospital, Marshfield, Wisconsin, and earned a masters degree in administrative medicine from UW-Madison.

Dr. Laurie Glimcher

President, Dana-Farber Cancer Institute

Laurie H. Glimcher, MD, is the President and CEO of the Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard CancerCenter, and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research.

Nancy Howell Agee

President and Chief Executive Officer, Carilion Clinic

Nancy Howell Agee is president and chief executive officer of Carilion Clinic, a nearly $2 billion not-for-profit integrated health system headquartered in Roanoke, Virginia, serving more than 1 million people in Virginia and West Virginia.

Carilion Clinic includes seven hospitals ranging from the third largest in Virginia to mid-sized community and small rural or critical access hospitals. Carilion also operates complementary business lines, including home health, imaging services, pharmacies and free-standing surgical clinics and has a large physician group with more than 1,000 employed physicians.

Before becoming CEO in 2011, Ms. Agee served as executive vice president and chief operating officer. During her tenure as COO, she co-led Carilion’s reorganization from a collection of hospitals to a fully integrated, physician-led clinic. The reorganization resulted in a partnership with Virginia Tech to create an allopathic medical school and research institute.

Ms. Agee is recognized nationally as a health care leader and currently serves as chair of the American Hospital Association, a membership organization representing the nation’s 5,000 hospitals and health care systems. She was named one of Modern Healthcare’s top 25 women in health care in 2017 and one of the national magazine’s 100 most influential people in health care in 2016 and 2017. She is a former member of The Joint Commission’s Board of Commissioners and past chair of the Virginia Hospital & Healthcare Association and the Virginia Center for Health Innovation.